<DOC>
	<DOC>NCT00100555</DOC>
	<brief_summary>The purpose of this trial is to study the clinical safety, tolerability, and efficacy of zoledronic acid compared to an oral bisphosphonate in postmenopausal women with osteoporosis.</brief_summary>
	<brief_title>A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Postmenopausal women between 45 and 79 years of age Must be osteopenic/osteoporotic Any women of childbearing potential Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Osteoporosis, osteopenia, post-menopausal, zoledronic acid</keyword>
</DOC>